The estimated Net Worth of Sonja Nelson is at least $5.57 Milione dollars as of 27 October 2023. Ms. Nelson owns over 12,778 units of NantKwest Inc stock worth over $4,226,267 and over the last 7 years she sold NK stock worth over $905,811. In addition, she makes $442,692 as Chief Financial Officer at NantKwest Inc.
Sign up
Ms. Nelson NK stock SEC Form 4 insiders trading
Sonja has made over 7 trades of the NantKwest Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she sold 12,778 units of NK stock worth $125,480 on 27 October 2023.
The largest trade she's ever made was selling 39,271 units of NantKwest Inc stock on 4 January 2021 worth over $534,871. On average, Sonja trades about 6,579 units every 114 days since 2018. As of 27 October 2023 she still owns at least 130,079 units of NantKwest Inc stock.
You can see the complete history of Ms. Nelson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sonja Nelson biography
Sonja Nelson serves as Chief Financial Officer of the Company since June 2018. Ms. Nelson previously served as our Chief Accounting Officer from May 2016 to June 2018 and has served as our VP/Corporate Controller since November 2015. Prior to joining the company, Ms. Nelson was Vice President and Corporate Controller at AltheaDx, Inc. from July 2014 through October 2015. Previously, Ms. Nelson was Senior Director and Controller at Cadence Pharmaceuticals, Inc. (acquired by Mallinckrodt plc) from May 2012 through June 2014. Prior to that, Ms. Nelson was Director, General Accounting at Cricket Communications, Inc., a $3 billion wireless services provider, (acquired by AT&T, Inc.) from September 2008 through May 2012. Ms. Nelson began her career with KPMG LLP, holds a Bachelor’s degree in accounting and taxation from the University of Applied Sciences in Pforzheim, Germany, and is a Certified Public Accountant.
What is the salary of Sonja Nelson?
As the Chief Financial Officer of NantKwest Inc, the total compensation of Sonja Nelson at NantKwest Inc is $442,692. There are 1 executives at NantKwest Inc getting paid more, with Barry Simon having the highest compensation of $454,440.
How old is Sonja Nelson?
Sonja Nelson is 47, she's been the Chief Financial Officer of NantKwest Inc since 2018. There are 7 older and no younger executives at NantKwest Inc. The oldest executive at NantKwest Inc is Frederick Driscoll, 69, who is the Lead Independent Director.
What's Sonja Nelson's mailing address?
Sonja's mailing address filed with the SEC is C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE, FL, 33301.
Insiders trading at NantKwest Inc
Over the last 9 years, insiders at NantKwest Inc have traded over $20,345,739 worth of NantKwest Inc stock and bought 4,163,265 units worth $55,365,252 . The most active insiders traders include Patrick Cambridge Equities,..., Steve Gorlin e Barry J. Simon. On average, NantKwest Inc executives and independent directors trade stock every 33 days with the average trade being worth of $5,362,832. The most recent stock trade was executed by Richard Adcock on 5 February 2021, trading 150,000 units of NK stock currently worth $4,873,500.
What does NantKwest Inc do?
NantKwest (NASDAQ: NK) is an innovative, clinical-stage, immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases. NantKwest is the leading producer of clinical dose forms of off-the-shelf natural killer (NK) cell therapies. The activated NK cell platform is designed to destroy cancer and virally-infected cells. The safety of these optimized, activated NK cells-as well as their activity against a broad range of cancers-has been tested in phase I clinical trials in Canada and Europe, as well as in multiple phase I and II clinical trials in the United States. By leveraging an integrated and extensive genomics and transcriptomics discovery and development engine, together with a pipeline of multiple, clinical-stage, immuno-oncology programs, NantKwest's goal is to transform medicine by bringing novel NK cell-based therapies to routine clinical care. NantKwest is a member of the NantWorks ecosystem of companies.
What does NantKwest Inc's logo look like?
Complete history of Ms. Nelson stock trades at NantKwest Inc, Motus GI Inc e Ambrx Biopharma
NantKwest Inc executives and stock owners
NantKwest Inc executives and other stock owners filed with the SEC include:
-
Barry Simon,
President, Chief Administrative Officer, Director -
Sonja Nelson,
Chief Financial Officer -
Cheryl Cohen,
Director -
Patrick Soon-Shiong,
Executive Chairman of the Board -
Frederick Driscoll,
Lead Independent Director -
John Thomas,
Independent Director -
Michael Blaszyk,
Independent Director -
Richard Adcock,
Chief Executive Officer -
John T Jr Potts,
Director -
Richard Kusserow,
Director -
Angela Wilson,
Chief Financial Officer -
Steve Gorlin,
Director -
Richard J. Tajak,
Chief Financial Officer -
Patrickmp 13 Ventures, Llc ...,
Chairman and CEO -
Patrick Chan Soon Shiong Fa...,
Chairman and CEO